Haemophilia : the official journal of the World Federation of Hemophilia·2010
Parosteal osteosarcoma, a bone cancer, has an excellent prognosis with surgical resection. Early-stage, low-grade tumors can be cured with adequate margins, while larger or recurrent tumors may require staged surgery.
Area of Science:
Orthopedic Oncology
Surgical Pathology
Background:
Parosteal osteosarcoma is a subtype of osteogenic sarcoma.
It generally presents with a favorable prognosis compared to other osteosarcomas.
Purpose of the Study:
To evaluate the surgical management and outcomes for parosteal osteosarcoma.
To define treatment strategies based on tumor grade and size.
Main Methods:
Review of case series focusing on surgical resection techniques.
Classification of tumors by grade (I-III) and size (<5 cm vs. larger).
Analysis of treatment outcomes including survival and recurrence rates.
Main Results:
Adequate resection of low- and moderate-grade parosteal osteosarcoma leads to long-term survival.
Small, low-grade lesions (<5 cm) are effectively treated with en bloc resection and 2.5 cm margins.
Larger Grade I-II lesions and recurrences benefit from a two-stage resection six months apart.
Grade III or intramedullary-involved lesions require high-grade osteosarcoma treatment protocols.
Surgical challenges like pathologic fracture, neurovascular compromise, and joint function preservation were managed.
Conclusions:
Parosteal osteosarcoma management is tailored to tumor characteristics.
Surgical resection with appropriate margins and techniques offers excellent outcomes.
Staged resection is effective for larger or recurrent low-grade parosteal osteosarcoma.